Rewriting the clinical and commercial rulebook with real-world data
This webinar explores how real-world data (RWD) and AI are transforming clinical development, evidence generation, and commercialization, particularly in rare diseases and brain cancer. Speakers discuss how integrated RWD helps identify geographically dispersed patients, optimize trial design, support biomarker-driven targeting, and improve commercial strategy, while AI and NLP enable deeper analysis of unstructured clinical data […]
How real-world data is transforming GLP-1 strategy, and the keys to launch success
This webinar explores how integrated real-world data (RWD) and AI are reshaping commercial strategy for GLP-1 therapies as the obesity and cardiometabolic markets rapidly expand. Speakers discuss how combining EMR, claims, payer, and prescription data helps manufacturers identify untreated patient populations, monitor launches in near real time, understand prescribing and channel trends, and address access […]
Trustworthy and novel AI in clinical trial planning
This pharmaphorum podcast explores how AI is transforming drug development and commercialization, with Norstella Chief Product Officer Kris Kaneta discussing the growing role of clinical AI powered by robust patient-level data. Kaneta explains how AI can move beyond administrative efficiency to deliver real strategic recommendations for clinical trials, commercialization and decision-making across the product lifecycle. […]
NorstellaLinQ: Identify obesity treatment opportunity before the market does
For GLP-1 therapies, traditional data sources alone aren’t enough to understand the full patient journey. NorstellaLinQ’s 74 billion data points give you the full picture and help you optimize GLP-1 launch strategies in real time. This infographic shows how NorstellaLinQ: Unlocks key information on patients, providers, systems, and payers Uncovers prescribing trends for GLP-1s weeks […]
Inside the Norstella Panel: The engine behind smarter access decisions
The Norstella Panel puts you in the room with the people who decide. Active P&T leaders. Payer and PBM decision makers. Provider and IDN influencers. The voices shaping coverage in real time. As the industry’s leading partner in access, Norstella delivers reach others simply can’t match. Download the infographic to see the scale, specialization, and […]
Norstella’s Real-World Data/AI Executive Forum highlights
The Norstella Real-World Data Executive Forum explores how real-world data (RWD) can accelerate treatment progress in neuro-oncology, particularly for small patient populations and rare subgroups whose outcomes take years to fully measure. Norstella’s mission to “smooth the path to life-saving therapies” guides its RWD strategy, including curating data elements that closely mirror clinical trial inclusion […]
Real-world data, real-world impact
This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance Wolkenbrod discussing how integrated real-world data (RWD) is improving patient access to therapies in multiple myeloma. By combining claims, EMR, lab, mortality, and physician note data, Norstella developed clinical profiles that helped identify patients at key disease stages and match […]
Ultimate real-world data showdown
This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance discussing how real-world data (RWD), EMR data, and AI are transforming pharma decision-making and patient care. Through a game-show-style conversation, they explore how integrated datasets and unstructured clinical data help generate real-world evidence, improve patient identification, accelerate therapies to market, […]
Real-world data revealed: Getting to know our experts
Real-World Data After Dark is a Norstella mini-series that blends late-night talk show energy with expert conversations on real-world data (RWD) and its importance to the pharmaceutical industry, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella. In this inaugural episode, chief clinician Dr. Madeline Naylor and senior principal of RWD Solutions Lance Wolkenbrod […]
Real-world data in 2025 and beyond: Closing the strategy gap
Real-world data has already proven its power to transform patient outcomes, accelerate clinical development, and strengthen commercial strategies, but its full value is realized only when pharma organizations approach it with a cohesive, forward-looking strategy. Our white paper, Real-world data in 2025 and beyond: Closing the strategy gap, surveyed 200 life sciences executives to gather […]